US Stock MarketDetailed Quotes

CSTL Castle Biosciences

Watchlist

20.030
+0.740+3.84%

Close Mar 17 16:00 ET

20.030
0.0000.00%

Post 16:20 ET

571.14MMarket Cap32.31P/E (TTM)

Castle Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Castle Biosciences Q4 2024 Earnings Date

Currency：USDFeb 27, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	83.89M	86.31M	+2.42M
Beat Est.	+26.87%	+30.54%	+2.89%
EPS	0.05	0.32	+0.27
Beat Est.	+148.95%	+455.56%	+554.40%

Analyst Rating

Strong Buy

Mar 3, 2025

Castle Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 71.624M	--
--	2025/Q1	-- / 80.552M	--
Feb 27, 2025	2024/Q4	86.311M / 83.887M	--
Nov 4, 2024	2024/Q3	85.782M / 78.992M	--
Aug 5, 2024	2024/Q2	87.002M / 69.367M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 71.624M--

--2025/Q1-- / 80.552M--

Feb 27, 20252024/Q486.311M / 83.887M--

Nov 4, 20242024/Q385.782M / 78.992M--

Aug 5, 20242024/Q287.002M / 69.367M--

Unlock Free Earnings Estimates

Open Account

Castle Biosciences Earnings Reports

Castle Biosciences | 10-K: FY2024 Annual Report

Feb 27 16:11 ET

Castle Biosciences | 8-K: Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results

Feb 27 16:08 ET

Castle Biosciences | 8-K: Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results

Jan 13 07:27 ET

Castle Biosciences | 10-Q: Q3 2024 Earnings Report

Nov 4, 2024 16:14 ET